Cancer-on-a-Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions

被引：51

作者：

Jiang, Xing ^{[1
,2
]}

Ren, Li ^{[1
,3
]}

Tebon, Peyton ^{[1
]}

Wang, Canran ^{[1
,4
]}

Zhou, Xingwu ^{[1
]}

Qu, Moyuan ^{[1
,5
,6
]}

Zhu, Jixiang ^{[1
,7
]}

Ling, Haonan ^{[1
,8
]}

Zhang, Shiming ^{[1
,9
]}

Xue, Yumeng ^{[1
,10
]}

Wu, Qingzhi ^{[1
,11
]}

Bandaru, Praveen ^{[1
]}

Lee, Junmin ^{[1
,12
]}

Kim, Han-Jun ^{[1
,12
]}

Ahadian, Samad ^{[1
,12
]}

Ashammakhi, Nureddin ^{[1
]}

Dokmeci, Mehmet R. ^{[1
,12
]}

Wu, Jinhui ^{[13
,14
]}

Gu, Zhen ^{[1
]}

Sun, Wujin ^{[1
,12
]}

Khademhosseini, Ali ^{[1
,12
]}

机构：

[1] Univ Calif Los Angeles, Calif Nanosyst Inst, Ctr Minimally Invas Therapeut, Dept Bioengn, Los Angeles, CA 90095 USA

[2] Nanjing Univ Chinese Med, Sch Nursing, Nanjing 210023, Peoples R China

[3] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China

[4] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai 200025, Peoples R China

[5] Zhejiang Univ, Sch Med, Sch Stomatol, Affiliated Hosp Stomatol, Hangzhou 310006, Zhejiang, Peoples R China

[6] Key Lab Oral Biomed Res Zhejiang Prov, Hangzhou 310006, Zhejiang, Peoples R China

[7] Guangzhou Med Univ, Sch Basic Med Sci, Dept Biomed Engn, Guangzhou 511436, Peoples R China

[8] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA

[9] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Peoples R China

[10] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710000, Peoples R China

[11] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China

[12] Terasaki Inst Biomed Innovat, Los Angeles, CA 90064 USA

[13] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Med, Nanjing 210093, Peoples R China

[14] Nanjing Univ, Sch Life Sci, Nanjing 210093, Peoples R China

来源：

SMALL | 2021年 / 17卷 / 07期

基金：

美国国家卫生研究院;

关键词：

cancer immunotherapy; cancer-on-a-chip; drug screening; high-throughput observation chamber; immune checkpoint inhibitors;

D O I：

10.1002/smll.202004282

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Cancer immunotherapies, including immune checkpoint inhibitor (ICI)-based therapies, have revolutionized cancer treatment. However, patient response to ICIs is highly variable, necessitating the development of methods to quickly assess efficacy. In this study, an array of miniaturized bioreactors has been developed to model tumor-immune interactions. This immunotherapeutic high-throughput observation chamber (iHOC) is designed to test the effect of anti-PD-1 antibodies on cancer spheroid (MDA-MB-231, PD-L1+) and T cell (Jurkat) interactions. This system facilitates facile monitoring of T cell inhibition and reactivation using metrics such as tumor infiltration and interleukin-2 (IL-2) secretion. Status of the tumor-immune interactions can be easily captured within the iHOC by measuring IL-2 concentration using a micropillar array where sensitive, quantitative detection is allowed after antibody coating on the surface of array. The iHOC is a platform that can be used to model and monitor cancer-immune interactions in response to immunotherapy in a high-throughput manner.

引用

页数：10

共 50 条

[1] Enhanced Antitumor Effect of the Combination of Bacille Calmette-Guerin and an Immune Checkpoint Inhibitor in Bladder Cancer-On-a-Chip
Choi, Se Young
Kim, Mirinae
Kang, Su Jeong
Choi, Young Wook
Maeng, Sejung
Kim, Sung-Hwan
Chang, In Ho
BIOCHIP JOURNAL, 2023, 17 (04) : 496 - 506
[2] ENHANCED ANTITUMOR EFFECT OF THE COMBINATION OF BACILLE CALMETTE-GUERIN AND AN IMMUNE CHECKPOINT INHIBITOR IN BLADDER CANCER-ON-A-CHIP
Wee, Chung Beum
Tae, Jong Hyun
Chang, In Ho
Kim, Tae-Hyoung
Myung, Soon Chul
Choi, Joongwon
Kim, Jung Hoon
Kim, Jin Wook
Lee, Yong Seong
Choi, Se Young
JOURNAL OF UROLOGY, 2024, 211 (05): : E357 - E357
[3] Enhanced antitumor effect of the combination of Bacille Calmette-Guerin and an immune checkpoint inhibitor in bladder cancer-on-a-chip
Choi, S. Y.
Tae, J. H.
Chi, B. H.
Chang, I. H.
T.-H, Kim
Myung, S. C.
Kim, J. H.
Kim, J. W.
Lee, Y. S.
EUROPEAN UROLOGY, 2023, 83 : S610 - S610
[4] ENHANCED ANTITUMOR EFFECT OF THE COMBINATION OF BACILLE CALMETTE-GUERIN AND AN IMMUNE CHECKPOINT INHIBITOR IN BLADDER CANCER-ON-A-CHIP
Choi, Se Young
Tae, Jong Hyun
Chi, Byung Hoon
Chang, In Ho
Kim, Tae-Hyoung
Myung, Soon Chul
Kim, Jung Hoon
Kim, Jin Wook
Lee, Yong Seong
JOURNAL OF UROLOGY, 2023, 209 : E186 - E186
[5] Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches
Sleeboom, Jelle J. F.
Amirabadi, Hossein Eslami
Nair, Poornima
Sahlgren, Cecilia M.
den Toonder, Jaap M. J.
DISEASE MODELS & MECHANISMS, 2018, 11 (03)
[6] Enhanced Antitumor Effect of the Combination of Bacille Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder Cancer-On-a-Chip
Choi, Se Young
Kim, Mirinae
Kang, Su Jeong
Choi, Young Wook
Maeng, Sejung
Kim, Sung-Hwan
Chang, In Ho
BIOCHIP JOURNAL, 2023,
[7] Enhanced Antitumor Effect of the Combination of Bacille Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder Cancer-On-a-Chip
Se Young Choi
Mirinae Kim
Su Jeong Kang
Young Wook Choi
Sejung Maeng
Sung-Hwan Kim
In Ho Chang
BioChip Journal, 2023, 17 (4) : 496 - 506
[8] A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor
Yu, Jui-Ling
Jang, Sophia R-J
APPLIED MATHEMATICS AND COMPUTATION, 2019, 362
[9] Development of Cancer-on-a-chip Technology for the Study of Tumor Microenvironment and Metabolism
Ericson, Daniel L.
Azukas, Joshua
Strey, Helmut H.
Rubenstein, David
FASEB JOURNAL, 2022, 36
[10] Cancer-on-a-chip for Drug Screening
Lee, I-Chi
CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (45) : 5407 - 5418

← 1 2 3 4 5 →